Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Buy
38,998
+1,012
+3% +$54.8K 0.07% 231
2025
Q4
$1.86M Buy
37,986
+11,502
+43% +$536K 0.05% 256
2025
Q3
$1.14M Buy
26,484
+2,506
+10% +$97.9K 0.04% 336
2025
Q2
$921K Sell
23,978
-1,176
-5% -$44.9K 0.03% 364
2025
Q1
$974K Buy
25,154
+11,664
+86% +$427K 0.04% 315
2024
Q4
$456K Sell
13,490
-2,273
-14% -$81.8K 0.02% 518
2024
Q3
$644K Buy
15,763
+1,531
+11% +$62.6K 0.04% 363
2024
Q2
$548K Buy
14,232
+1,516
+12% +$63.8K 0.04% 365
2024
Q1
$545K Buy
12,716
+2,738
+27% +$113K 0.05% 321
2023
Q4
$370K Buy
+9,978
New +$358K 0.05% 349

Other funds holding GSK

Atomi Financial Group's GSK Position: Q1 2026 in Review

Atomi Financial Group increased its GSK (GSK) stake by 2.7% in Q1 2026, buying an estimated $54.8K and bringing the position to 38,998 shares worth $2.15M. The position accounts for 0.07% of the portfolio, ranked #231.

Atomi Financial Group first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Atomi Financial Group held 38,998 shares of GSK worth $2.15M as of Q1 2026.
  • Atomi Financial Group bought 1,012 GSK shares in Q1 2026, an estimated $54.8K.
  • GSK made up 0.07% of Atomi Financial Group's portfolio in Q1 2026, its #231 holding.
  • Atomi Financial Group first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.